These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37953268)

  • 1. Predictive value of quantitative fetal fibronectin for spontaneous preterm birth in asymptomatic pregnancies: a systematic literature review and meta-analysis.
    Ruma MS; Betts M; Dodman S; Neupane B
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2279923. PubMed ID: 37953268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study
    Levine LD; Downes KL; Romero JA; Pappas H; Elovitz MA
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3792-3800. PubMed ID: 29727248
    [No Abstract]   [Full Text] [Related]  

  • 4. Mid-gestational changes in cervicovaginal fluid cytokine levels in asymptomatic pregnant women are predictive markers of inflammation-associated spontaneous preterm birth.
    Amabebe E; Chapman DR; Stern VL; Stafford G; Anumba DOC
    J Reprod Immunol; 2018 Apr; 126():1-10. PubMed ID: 29367099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of quantitative fetal fibronectin to predict spontaneous preterm birth: A meta-analysis.
    Chen J; Gong G; Zheng W; Xu J; Luo X; Zhang Y
    Int J Gynaecol Obstet; 2021 May; 153(2):220-227. PubMed ID: 33336362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.
    Ravi M; Beljorie M; El Masry K
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined fetal fibronectin and cervical length and spontaneous preterm birth in asymptomatic triplet pregnancies.
    Fox NS; Rebarber A; Roman AS; Klauser CK; Peress D; Saltzman DH
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2308-11. PubMed ID: 22563765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
    Melchor JC; Khalil A; Wing D; Schleussner E; Surbek D
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal fibronectin testing for reducing the risk of preterm birth.
    Berghella V; Saccone G
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD006843. PubMed ID: 31356681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic high-risk women.
    Tran TL; Jwala S; Terenna C; McGregor A; Das A; Baxter JK; Berghella V
    J Matern Fetal Neonatal Med; 2020 Aug; 33(15):2628-2634. PubMed ID: 30612481
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis.
    Deshpande SN; van Asselt AD; Tomini F; Armstrong N; Allen A; Noake C; Khan K; Severens JL; Kleijnen J; Westwood ME
    Health Technol Assess; 2013 Sep; 17(40):1-138. PubMed ID: 24060096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of blood staining on cervicovaginal quantitative fetal fibronectin concentration and prediction of spontaneous preterm birth.
    Hezelgrave NL; Kuhrt K; Cottam K; Seed PT; Tribe RM; Shennan AH
    Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():103-108. PubMed ID: 27918947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative fetal fibronectin screening in asymptomatic high-risk patients and the spectrum of risk for recurrent preterm delivery.
    Kurtzman J; Chandiramani M; Briley A; Poston L; Das A; Shennan A
    Am J Obstet Gynecol; 2009 Mar; 200(3):263.e1-6. PubMed ID: 19254585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of fetal fibronectin for assessing preterm birth risk in asymptomatic pregnant women: a systematic review and meta-analysis.
    Dos Santos F; Daru J; Rogozińska E; Cooper NAM
    Acta Obstet Gynecol Scand; 2018 Jun; 97(6):657-667. PubMed ID: 29355887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
    Jun SY; Lee JY; Kim HM; Kim MJ; Cha HH; Seong WJ
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):241. PubMed ID: 31296172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women.
    Abbott DS; Radford SK; Seed PT; Tribe RM; Shennan AH
    Am J Obstet Gynecol; 2013 Feb; 208(2):122.e1-6. PubMed ID: 23164760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of predictive models for QUiPP App v.2: tool for predicting preterm birth in asymptomatic high-risk women.
    Watson HA; Seed PT; Carter J; Hezelgrave NL; Kuhrt K; Tribe RM; Shennan AH
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):348-356. PubMed ID: 31325332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal fibronectin testing for reducing the risk of preterm birth.
    Berghella V; Hayes E; Visintine J; Baxter JK
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD006843. PubMed ID: 18843732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.